DOCSLIB.ORG

Pain Drug Comparison Chart Karen Pantazis, M.D

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pain Drug Comparison Chart Karen Pantazis, M.D Information provided by Sutter Health’s MyLifeStages and pain management specialist Pain Drug Comparison Chart Karen Pantazis, M.D. Painkillers are among the most commonly used drugs in the United States. Deciding which to use deserves careful consideration. Use this quick comparison chart to COMMON SENSE help guide a conversation with your doctor about which CONSIDERATIONS medications are best and safest for you. • Talk with your doctor about medication dosage and possible contraindications. • Never take any drugs when you are pregnant without first consulting your doctor. • Exercise caution with sensitive groups such as children, the elderly and those with serious health conditions. OVER THE COUNTER Classification Brand Name Generic Name Best Used For Common Side Effects Warnings Bayer Aspirin Minor aches and pains, fever • GI bleeding • May contribute to Bufferin reduction and • Increased bleeding macular degeneration anti-inflammatory • Ulcers • Risk of Reyes syndrome in children Ascriptin and teens Aspirin Ecotrin • Do not combine with blood thinner Family St. Joseph’s medication • Can cause tinnitus in high doses • Can cause kidney problems Tylenol Acetaminophen Pain and fever • Itching/swelling • Liver damage possible if you take Excedrin reduction (especially of the face/ more than recommended dose or you tongue/throat) drink alcohol. Acetaminophen • Rash • OTC cough and flu products contain • Dizziness acetaminophen. It can add up quickly. • Bloody stools Limit total dose per day to 2000 mg. • Stomach bleeding Advil Ibuprofen, naproxen Pain, fever reduction and • Heartburn • May increase risk of Motrin – also known as non anti-inflammatory • Nausea cardiac events and stroke steroidal • Rash • Increases risk of GI bleeding and Aleve NSAIDs • Dizziness perforation • Stomach pain • Can cause kidney problems OVER THE COUNTER [con’t] Classification Brand Name Generic Name Best Used For Common Side Effects Warnings Midol Preps Combinations of For headaches, • Dizziness • Consider all warnings for aspirin, acet- acetaminophen, bloating, fatigue and • GI bleeding aminophen and NSAIDs like ibuprofen, caffeine, naproxen, menstrual symptoms • GI upset since combination drugs may combine Combination aspirin • Irritability one or more classes. Drugs • Nervousness Vanquish Combination For headaches, • Irritation of stomach or of aspirin, migraines, headaches, intestines Painkillers acetominophen and muscle aches, • Nervousness combining one caffeine menstrual aches, or • Nausea or more classes other minor aches and • Taste problems of OTC drugs. pains due to sinusitis, • Trouble sleeping arthritis, or colds • Ulcer from stomach acid Excedrin Combinations of Migraine pain • Dizziness Migraine acetaminophen, • GI bleeding caffeine and • GI upset ibuprofen • Irritability • Nervousness PRESCRIPTION Classification Brand Name Generic Name Best Used For Common Side Effects Warnings Vicodin Hydrocodone and Moderate to • Constipation, nausea, respiratory • Do not overtake these medications! Norco acetaminophen Severe Pain depression in high doses or when Take ONLY as prescribed. mixed with other meds or alcohol, Lortab / Lorcet • Can lead to death from respiratory can lead to death Opioid depression if overtaken or mixed with Analgesics other sedatives, including alcohol. Oxycodone Oxycodone Severe Pain • Can lead to dependence and tolerance, Percocet Oxycodone and which are different than addiction. acetaminophen MS ER / Kadian Morphine • Can lead to addiction, especially in high risk individuals Methadone Methadone Dilaudid Hydromorphone Opana Oxymorphone Duragesic Patch Fentanyl Patch Neuropathic Pain Medication Moderate to • Dizziness • Do not stop medication suddenly Severe Pain • Nausea Neurontin Gabapentin Non- Ultram Tramadol Opioid Lyrica Pregabalin Cymbalta Duloxetine Analgesics Topamax Topiramate Pamelor Nortriptylline Opioid Agonist / Antagonists Butrans Bupronorphene Patch.
Load more

Recommended publications
  • Confusing Brand Names: Nightmare of Medical Profession
    Original Article www.jpgmonline.com Confusing brand names: Nightmare of medical profession Rataboli PV, Garg A Department of Pharma- ABSTRACT cology and Therapeutics, Objective: India has more than 20,000 registered pharmaceutical manufacturers. Consequently, there is a Goa Medical College, Bambolim, Goa 403202, flood of brand names to choose from. We conducted this study to analyse and sort out the multitudinous India brand names thronging the Indian market, and identified those that could create a possible confusion. Materials and Methods: Recent issues of drug formularies like Indian Drug Review, Drug Index, and Monthly Correspondence: Index of Medical Specialities-India were checked and all the brand names given were included. Some other Amit Garg, MD brand names that are available with the pharmacists but are not included in these indexes were also included E-mail: [email protected] in the study for analysis. Observations: Potentially confusing brand names were sorted out and categorised according to the severity of damage they can cause if misinterpreted by the pharmacist or the patient. Subgroups were made according to the brand name, the generic name, and the manufacturers of the drug. Conclusion: Several brand names are strikingly identical, similar looking (orthographic), or similar sounding (phonological). Preventing this possible confusion is not the work of any one person involved. We describe the Received : 09-08-04 role of prescribing doctors, dispensing pharmacists, consumer patients, and the manufacturing companies to Review completed : 30-09-04 prevent “wrong prescribing” due to similarities in brand names. Accepted : 22-12-04 PubMed ID : 15793332 J Postgrad Med 2005;51:13-6 KEY WORDS: Identical; look-alike; sound-alike; confusing; brand names rescribing drugs with their brand name is an essential the patients, doctors, pharmacists, and the drug manufacturers were P part of medical practice.
    [Show full text]
  • Medicaid) Enhanced Care Plus (HARP) 2021 Drug Formulary Emblemhealth Enhanced Care and Enhanced Care Plus Formulary 2021 Formulary (List of Covered Drugs
    Enhanced Care (Medicaid) Enhanced Care Plus (HARP) 2021 Drug Formulary EmblemHealth Enhanced Care and Enhanced Care Plus Formulary 2021 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT some of the drugs covered by your plan. When this drug list (formulary) refers to “we,” “us,” or “our,” it means EmblemHealth. When it refers to “plan” or “our plan,” it means EmblemHealth Enhanced Care (Medicaid) or Enhanced Care Plus (HARP). This document includes a list of the drugs (formulary) for our plan which is current as of 10/1/2021. For a complete updated formulary, please call Customer Service at 888-447-7364 (TTY: 711). Our hours are 8 am to 6 pm, Monday through Friday and 10 am to 1 pm, Saturday and Sunday. A representative will be happy to help. You can also check our website at emblemhealth.com. You must use network pharmacies to use your prescription drug benefit. The formulary and pharmacy network may change. Effective Oct. 1, 2021, New York State Medicaid will implement a single statewide Medication Assisted Treatment (MAT) formulary for opioid dependence agents and opioid antagonists. i EMBLEMHEALTH ENHANCED CARE AND ENHANCED CARE PLUS FORMULARY What is the EmblemHealth Enhanced Care and Enhanced Care Plus Formulary? A formulary is a list of covered drugs selected by our plan with help from a team of health care professionals. It represents the prescription therapies believed to be a necessary part of a quality treatment program. Our plan will cover the drugs listed in our formulary as long as the drug is medically necessary, the prescription is filled at a plan network pharmacy, and other plan rules are followed.
    [Show full text]
  • Update on the Management of Pain, Agitation, and Delirium in the ICU
    Update on the Management of Pain, Agitation, and Delirium in the ICU Kevin E. Anger, Pharm.D., BCPS Gilles Fraser, Pharm.D., MCCM Paul M. Szumita, Pharm.D., BCCCP, Manager Investigational Drug Clinical Pharmacist in Critical BCPS, FCCM Service Brigham and Women’s Care Clinical Pharmacy Practice Manager Hospital Maine Medical Center Brigham and Women’s Hospital Boston, Massachusetts Portland, Maine Boston, Massachusetts Disclosures • Faculty have nothing to disclose. Objectives • Describe recent literature on management of pain, agitation, and delirium (PAD) in the intensive care unit (ICU). • Apply key concepts in the selection of sedatives, analgesics, and antipsychotic agents in critically ill patients. • Recommend methods to overcome key barriers to optimizing pain, sedation, and delirium pharmacotherapy in critically ill patients. Case-Based Approach to Pain Management in the ICU Kevin E. Anger, Pharm.D., BCPS Manager Investigational Drug Service Brigham and Women’s Hospital Boston, Massachusetts Time for a Poll How to vote via the web or text messaging From any browser From a text message Pollev.com/ashp 22333 152964 How to vote via text message How to vote via the web Question #1 DT is a 70 yo male w/ COPD, S/P XRT for NSC lung CA, now admitted to the medical ICU for respiratory failure secondary to pneumonia meeting ARDS criteria. Significant home medications include oxycodone sustained release 40mg TID, oxycodone 10- 20mg Q4hrs PRN pain, Advair 500/50mcg BID, ASA 81mg QD, and albuterol neb Q4hrs PRN. DT is intubated is currently
    [Show full text]
  • 022450Orig1s000
    CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 022450Orig1s000 CLINICAL PHARMACOLOGY AND BIOPHARMACEUTICS REVIEW(S) CLINICAL PHARMACOLOGY REVIEW NDA 22-450 Submission Dates 05/13/2009 Brand Name - Generic Name IV acetaminophen Reviewer Ping Ji, Ph.D. Team Leader Suresh Doddapaneni, Ph.D. PM Primary Reviewers Ping Ji. Ph.D. PM Team Leader Yaning Wang, Ph.D. OCP Division Division of Clinical Pharmacology-II OND Division Division of Anesthesia, Analgesia, and Rheumatology Products Sponsor Cadence Pharmaceuticals, Inc. Relevant IND(s) 58,362 Submission Type; Code 505 (b) (2) P Formulation; Strength(s) Sterile solution for intravenous infusion, 1000 mg/vial Indication Treatment of acute pain and fever Proposed Dosing Regimen Single or repeated dose via a 15-minute intravenous infusion. The dose administered varied depending on age and body weight. Table of Contents Table of Contents.................................................................................................................1 1. Executive Summary.....................................................................................................2 1.1. Recommendations............................................................................................ 2 1.2. Phase IV Commitments................................................................................... 2 2. Question-Based Review...............................................................................................9 2.1. General Attributes...........................................................................................
    [Show full text]
  • Pharmacists' Roles on the Pain Management Team, Fall 2014
    Fall 2014, Volume 8, Issue 2 Canadian Pharmacy > Research > Health Policy > Practice > Better Health Pharmacists’ Roles on the Pain Management Team harmacists are an important resource for managing pain in their patients, in order to both optimize treatment and Pprevent the unintended consequences of potent analgesics. While the role of pharmacists in pain management was first addressed inthe Translator Summer 2012 edition1, this rapidly evolving area of pharmacy practice has generated a number of innovative models that highlight the unique role of the pharmacist. As Canadian pharmacists embrace expanded scopes of practice, there is an opportunity to specifically leverage their services to assist patients in managing their pain. This issue of the Translator highlights four different approaches to enhanced involvement of pharmacists in the management of chronic pain: n Pharmacist-led management of chronic pain: a randomized controlled exploratory trial from the UK n A pharmacist-initiated intervention trial in osteoarthritis n A pharmacist-led pain consultation for patients with concomitant substance use disorders n The impact of pharmacists in translating evidence to patients with low back pain 1 The Translator, Summer 2012, 6:3 Pharmacist-led management of chronic pain in primary care: results from a randomized controlled exploratory trial Bruhn H, Bond CM, Elliott AM, et al. Pharmacist-led management of chronic pain in primary care; results from a randomized controlled exploratory trial. BMJ Open 2013;3:e002361. Issue: In the UK, an estimated 80% of medication review of each patient’s medical chronic pain sufferers still report pain after Pharmacist prescribing and records, followed by a face-to-face consul- four years of follow-up.1 Most patients refer reviewing pain medication may tation.
    [Show full text]
  • Pain Management in People Who Have OUD; Acute Vs. Chronic Pain
    Pain Management in People Who Have OUD; Acute vs. Chronic Pain Developer: Stephen A. Wyatt, DO Medical Director, Addiction Medicine Carolinas HealthCare System Reviewer/Editor: Miriam Komaromy, MD, The ECHO Institute™ This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under contract number HHSH250201600015C. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government. Disclosures Stephen Wyatt has nothing to disclose Objectives • Understand the complexities of treating acute and chronic pain in patients with opioid use disorder (OUD). • Understand the various approaches to treating the OUD patient on an agonist medication for acute or chronic pain. • Understand how acute and chronic pain can be treated when the OUD patient is on an antagonist medication. Speaker Notes: The general Outline of the module is to first address the difficulties surrounding treating pain in the opioid dependent patient. Then to address the ways that patients with pain can be approached on either an agonist of antagonist opioid use disorder treatment. Pain and Substance Use Disorder • Potential for mutual mistrust: – Provider • drug seeking • dependency/intolerance • fear – Patient • lack of empathy • avoidance • fear Speaker Notes: It is the provider that needs to be well educated and skillful in working with this population. Through a better understanding of opioid use disorders as a disease, the prejudice surrounding the encounter with the patient may be reduced.
    [Show full text]
  • Drug Formulary 2019
    2019 PREHOSPITAL FORMULARY EL DORADO COUNTY EMERGENCY MEDICAL SERVICES AGENCY 2900 Fair Lane Court Placerville, CA 95667 17th Edition Effective: July 1, 2019 TABLE OF CONTENTS Acetaminophen ................................................................................................................. 3 Activated Charcoal ........................................................................................................... 4 Adenocard ........................................................................................................................... 5 Albuterol Sulfate .................................................................................................................. 6 Amiodarone ......................................................................................................................... 7 Aspirin ..................................................................................................................................... 9 Atropine Sulfate................................................................................................................. 10 Atrovent (Duoneb) ........................................................................................................... 12 Calcium Chloride .............................................................................................................. 13 Dextrose 50% in Water ..................................................................................................... 14 Dextrose 10% in 100cc NS…………………………………………………………… 14 Diphenhydramine
    [Show full text]
  • Perioperative Pain Management for the Chronic Pain Patient with Long-Term Opioid Use
    1.5 ANCC Contact Hours Perioperative Pain Management for the Chronic Pain Patient With Long-Term Opioid Use Carina Jackman In the United States nearly one in four patients present- patterns of preoperative opioid use. Approximately one ing for surgery reports current opioid use. Many of these in four patients undergoing surgery in the study re- patients suffer from chronic pain disorders and opioid ported preoperative opioid use (23.1% of the 34,186-pa- tolerance or dependence. Opioid tolerance and preexisting tient study population). Opioid use was most common chronic pain disorders present unique challenges in regard in patients undergoing orthopaedic spinal surgery to postoperative pain management. These patients benefi t (65%). This was followed by neurosurgical spinal sur- geries (55.1%). Hydrocodone bitartrate was the most from providers who are not only familiar with multimodal prevalent medication. Tramadol and oxycodone hydro- pain management and skilled in the assessment of acute pain, chloride were also common ( Hilliard et al., 2018 ). but also empathetic to their specifi c struggles. Chronic pain Given this signifi cant population of surgical patients patients often face stigmas surrounding their opioid use, with established opioid use, it is imperative for both and this may lead to underestimation and undertreatment nurses and all other providers to gain an understanding of their pain. This article aims to review the challenges of the complex challenges chronic pain patients intro- presented by these complex patients and provide strate- duce to the postoperative setting. gies for treating acute postoperative pain in opioid-tolerant patients. Defi nitions Common pain terminology as defined by the Chronic Pain and Long-Term International Association for the Study of Pain, a joint Opioid Use consensus statement by the American Society of Addiction Medicine, the American Academy of Pain The burden of chronic pain in the United States is stag- Medicine and the American Pain Society (2001 ), and the gering.
    [Show full text]
  • Menu of Pain Management Clinic Regulation
    Menu of Pain Management Clinic Regulation The United States is in the midst of an unprecedented epidemic of prescription drug overdose deaths.1 More than 38,000 people died of drug overdoses in 2010, and most of these deaths (22,134) were caused by overdoses involving prescription drugs.2 Three-quarters of prescription drug overdose deaths in 2010 (16,651) involved a prescription opioid pain reliever (OPR), which is a drug derived from the opium poppy or synthetic versions of it such as oxycodone, hydrocodone, or methadone.3 The prescription drug overdose epidemic has not affected all states equally, and overdose death rates vary widely between states. States have the primary responsibility to regulate and enforce prescription drug practice. Although state laws are commonly used to prevent injuries and their benefits have been demonstrated for a variety of injury types,4 there is little information on the effectiveness of state statutes and regulations designed to prevent prescription drug abuse and diversion. This menu is a first step in assessing pain management clinic laws by creating an inventory of state legal strategies in this domain. Introduction One type of law aimed at preventing inappropriate prescribing is regulation of pain management clinics, often called “pill mills” when they are sources of large quantities of prescriptions. Pill mills have become an increasing problem in the prescription drug epidemic, and laws have been enacted to prevent these facilities from prescribing controlled substances inappropriately. A law was included in this resource as a pain management clinic regulation if it requires state oversight and contains other requirements concerning ownership and operation of pain management clinics, facilities, or practice locations.
    [Show full text]
  • Palliative Care Symptom Guide
    July 2019 UPMC PALLIATIVE AND SUPPORTIVE INSTITUTE Palliative Care Symptom Guide Table of Contents: Pain Management ……………………………………………………………………………………………………………………….. Assessment …………………………………………………………………………………………………………………………… 1 Adjuvant and Non-Opioid Agents for Pain ……………………………………………………………………………………….... 2 Principles of Opioid Therapy ……………………………………………………………………………………………….….…. 3-4 Select Opioid Products ……………………………………………………………………………………………………………… 5 Opioid Equianalgesic Equivalencies ………………………………………………………………………...…………………..… 6 Patient Controlled Analgesia (PCA) ……………………………………………………………………………………………….. 7 Opioid Induced Constipation ……………………………………………………………………………………………………… 8-9 Prescribing Outpatient Naloxone ………………………………………………………………………………………………… 10 Interventional Pain Management …………………………………………………………………………………………………. 11 Medical Cannabinoids ……………………………………………………………………………………………………………… 12 Dyspnea ………………………………………………………………………………………………………………………………… Assessment ………………………………………………………………………………………………………………………… 13 Treatment …………………………………………………………………………………………………………………………… 14 Nausea and Vomiting Treatment ……………………………………………………………………………………………..……… 15 Delirium …………………………………………………………………………………………………………………………………. 16 Diagnostic Criteria ……………………………………………………………………………….……………………….………... 17 Treatment ………………………………………………………………………………..…………………………………………. 18 Depression and Anxiety Treatment ……………………………………………………..…………..…………………………….…. 19 Oral Secretions ……………………………………………………..…………………………………………………………………. 20 Spirituality Pearls ……………………………………………………..………………………………………………………………. 21 Palliative
    [Show full text]
  • Veterinary Anesthesia and Pain Management Secrets / Edited by Stephen A
    Publisher: HANLEY & BELFUS, INC. Medical Publishers 210 South 13th Street Philadelphia, PA 19107 (215) 546-7293; 800-962-1892 FAX (215) 790-9330 Web site: http://www.hanleyandbelfus.com Note to the reader Although the information in this book has been carefully reviewed for cor­ rectness of dosage and indications, neither the authors nor the editor nor the publisher can accept any legal responsibility for any errors or omissions that may be made. Neither the publisher nor the editor makes any warranty, expressed or implied, with respect to the material contained herein. Before prescribing any drug. the reader must review the manu­ facturer's correct product information (package inserts) for accepted indications, absolute dosage recommendations. and other information pertinent to the safe and effective use of the product described. This is especially important when drugs are given in combination or as an adjunct to other forms of therapy Library of Congress Cataloging-in-Publication Data Veterinary anesthesia and pain management secrets / edited by Stephen A. Greene. p. em. - (The Secrets Series®) Includes bibliographical references (p.). ISBN 1-56053-442-7 (alk paper) I. Veterinary anesthesia-Examinations, questions. etc. 2. Pain in animals­ Treatment-Examinations, questions, etc. I. Greene, Stephen A., 1956-11. Series. SF914.V48 2002 636 089' 796'076--dc2 I 2001039966 VETERINARY ANESTHESIA AND PAIN MANAGEMENT SECRETS ISBN 1-56053-442-7 © 2002 by Hanley & Belfus, Inc. All rights reserved. No part of this book may be repro­ duced, reused, republished. or transmitted in any form, or stored in a database or retrieval system, without written permission of the publisher Last digit is the print number: 9 8 7 6 5 4 3 2 CONTRIBUTORS G.
    [Show full text]
  • Can I Drink Alcohol 24 Hours After Taking Tramadol
    CAN I DRINK ALCOHOL 24 HOURS AFTER TAKING TRAMADOL Can I Drink Alcohol 24 Hours After Taking Tramadol can i take tramadol and codeine tramadol xanax combination wrench e z tramadol withdrawal forum tramadol helps anxiety attack tramadol vs percocet webmd ovulation tramadol 50 mg for dog tramadol feeling faint and nauseous in the morning tramadol gi tabletas electronics obat tramadol buat mabuk monkey snort tramadol high interaction ondansetron and tramadol tramadol and oxycodone high can 50 mg tramadol get you high tramadol plus paracetamol dosage per weight for benadryl can you take cymbalta & tramadol together quotes tramadol eczema tramadol e paracetamol drug study tramadol 100mg kopen op combinatie tramadol en diclofenac potassium 50mg tramadol muscle twitching tramadol y paracetamol overdose and liver tramadol brand name uk lottery tramadol and percocet mixed with advil tramadol hydrochloride side effects canine chemotherapy can tramadol be combined with tylenol voltaren or tramadol side tramadol tablets 200mg to g\/dl tramadol lannacher 100 mg trazodone side effects arcoxia and tramadol together again for the first time tramadol over the counter equivalent 100 milligram tramadol side tramadol 50 mg how much codeine is in promethazine b tracet ex tramadol paracetamol brand names side effects of tramadol and paracetamol combination locks natural tramadol detox cold turkey tramadol er 300 mg price tramadol tb pret tramadol doctor shopping florida tramadol 50 mg dzialanie witaminy tramadol pvp tramadol drug test 12 panel tramadol hydrochloride
    [Show full text]